Hormone Replacement Therapy (HRT) Market Size, Share, Growth Analysis, By Product(Estrogen & Progesterone Replacement Therapy, HGH replacement therapy, Thyroid hormone replacement therapy, Testosterone Replacement Therapy), By Route Of Administration(Oral, Parenteral, Transdermal, Others), By Disease Type(Menopause, Hypothyroidism, Male hypogonadism, Growth hormone deficiency), By Region - Industry Forecast 2024-2031

Hormone Replacement Therapy (HRT) Market size was valued at USD 24.97 billion in 2019 and is poised to grow from USD 26.87 billion in 2023 to USD 49.25 billion by 2031, growing at a CAGR of 7.83% in the forecast period (2024-2031).

Hormone replacement therapy has been successfully utilized for many years to treat menopause-related illnesses in women. As a result, hot flashes, osteoporosis risks, and other menopause symptoms have decreased as well. These treatments are also fueling the market's expansion due to the rise in other hormone-related illnesses targeted at various age groups that impact both women and men. As a result, during the forecast period, diseases such thyroid disorders, growth deficiencies, and others are also expected to accelerate market expansion globally.

The availability of long-acting hGH products and factors including the increased prevalence of target diseases are driving the expansion of the hormone replacement therapy (HRT) market. The American Thyroid Association estimates that 12% of Americans will experience thyroid disease at some point in their lives. Additionally, it stated that about 20 million Americans suffer from thyroid disease. Numerous investigations revealed that individuals receiving HRT treatment probably had a low risk of COVID-19 infection and mortality.

US Hormone Replacement Therapy (HRT) Market is poised to grow at a sustainable CAGR for the next forecast year.